D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
OLMA holding history
Olema Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OLMA overviewAll 13F holders of OLMAFull Q2 2026 holdings
- Shares (Q2 2026)
- 55,519
- Value
- $694.5K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 55,519 | $694.5K | <0.1% | +16,289+41.5% | Added | Holders |
| Q1 2026 | 39,230 | $584.9K | <0.1% | +29,276+294.1% | Added | Holders |
| Q4 2025 | 9,954 | $248.8K | <0.1% | +9,954 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −12,445−100.0% | Sold out | Holders |
| Q4 2024 | 12,445 | $72.6K | <0.1% | −13,148−51.4% | Reduced | Holders |
| Q3 2024 | 25,593 | $305.6K | <0.1% | +4,534+21.5% | Added | Holders |
| Q2 2024 | 21,059 | $227.9K | <0.1% | +10,959+108.5% | Added | Holders |
| Q1 2024 | 10,100 | $114.3K | <0.1% | −1,789−15.0% | Reduced | Holders |
| Q4 2023 | 11,889 | $166.8K | <0.1% | +11,889 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −154,081−100.0% | Sold out | Holders |
| Q2 2022 | 154,081 | $627.0K | <0.1% | −58,289−27.4% | Reduced | Holders |
| Q1 2022 | 212,370 | $905.0K | <0.1% | +124,288+141.1% | Added | Holders |
| Q4 2021 | 88,082 | $824.0K | <0.1% | +20,656+30.6% | Added | Holders |
| Q3 2021 | 67,426 | $1.86M | <0.1% | +26,622+65.2% | Added | Holders |
| Q2 2021 | 40,804 | $1.14M | <0.1% | −75,725−65.0% | Reduced | Holders |
| Q1 2021 | 116,529 | $3.87M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.